Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

20.0%

6 terminated/withdrawn out of 30 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

10%

3 trials in Phase 3/4

Results Transparency

1 of 12 completed trials have results

Key Signals

3 recruiting1 with results6 terminated

Enrollment Performance

Analytics

N/A

9(42.9%)

Phase 2

6(28.6%)

Phase 3

3(14.3%)

Phase 1

2(9.5%)

Early Phase 1

1(4.8%)

21Total

N/A(9)

Phase 2(6)

Phase 3(3)

Phase 1(2)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (30)

Showing 20 of 30 trials

NCT04670016Completed

HRQL and Symptom Assessment for Patients With DIPG or Recurrent and Re-irradiated Brain Tumours and Their Caregivers

Role: collaborator

NCT07460726Not Yet Recruiting

PRIAPUS-PCa Study: Stereotactic Body Radiation Therapy (SBRT) and Androgen Deprivation Therapy (ADT) Impact on Sexual Function on Men With Unfavorable Intermediate Risk Prostate Cancer

Role: lead

NCT03118986Phase 2Recruiting

RCT of Olanzapine for Control of CIV in Children Receiving Highly Emetogenic Chemotherapy

Role: collaborator

NCT03895359Phase 3Recruiting

Transarterial Chemoembolization (TACE) Versus TACE Plus Stereotactic Body Radiation Therapy (SBRT) in Liver Carcinoma

Role: collaborator

NCT05667298Phase 1Active Not Recruiting

Organ-Preserving Endoscopic Resection & Adjuvant RADIO-immuno-chemotherapy for Esophageal Cancer

Role: collaborator

NCT01404156Phase 2Completed

Preoperative Chemotherapy vs. Chemoradiation in Esophageal / GEJ Adenocarcinoma

Role: collaborator

NCT05402241Completed

IRD at Admission Predicts Survival of GBM Patients - a Prospective Pilot Study

Role: collaborator

NCT03322072Not ApplicableActive Not Recruiting

Calypso Guided High Precision Stereotactic Ablative Radiosurgery for Lung TUmours Using Real-Time Tumour Tracking & Respiratory Gating

Role: lead

NCT01423474Not ApplicableCompleted

Prostate Accurately Targeted Radiotherapy Investigation of Overall Treatment Time

Role: lead

NCT04530006Not ApplicableRecruiting

Acetyl-Amantadine as a Biomarker in Patients With Glioblastoma

Role: lead

NCT02331290Unknown

Excretion of Acetylamantadine (AA) by Lung Cancer Patients During a Chemotherapy Regimen

Role: collaborator

NCT03378466Phase 2Terminated

Heparin Anticoagulation in Septic Shock

Role: collaborator

NCT05115422Not ApplicableUnknown

Feasibility and Acceptability of a Virtual 'Coping With Brain Fog' Intervention for Young Adults With Cancer

Role: collaborator

NCT01976962Not ApplicableTerminated

Functional MR-guided Stereotactic Body Radiation Therapy of Prostate Cancer

Role: lead

NCT01813370Completed

A Registry for Patients Treated on the Clinical Trial TAX 3503

Role: collaborator

NCT03837132Completed

Early Palliative Care on Quality of Life of Patients With Advanced Pancreas Cancer

Role: collaborator

NCT02517593Phase 1Completed

Genetic Risk Estimation of Breast Cancer Prior to Preventive Medication Uptake

Role: collaborator

NCT02239601Not ApplicableCompleted

Chemotherapy Induced Peripheral Neuropathy. Could Physical Therapy Help Treat Symptoms?

Role: lead

NCT03131011Not ApplicableTerminated

Body-image Satisfaction Following Permanent Black or Invisible UV Ink Tattoos

Role: lead

NCT02055170Phase 2Terminated

Neoadjuvant Finasteride for Patients With Non-small Cell Lung Cancer

Role: lead